The novel coronavirus has hit home at Biogen, where three executives who traveled to a headquarters management meeting have tested positive for the illness.
At last week's meeting, a “number of attendees reported varying degrees of flu-like symptoms,” the company said in a statement reported in numerous publications. Some have confirmed influenza, while, so far, three joined the COVID-19 case count.
It's exactly the sort of development drugmakers are trying to avoid by restricting travel, pulling out of conferences and pushing employees who might be exposed to work from home.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,